250 related articles for article (PubMed ID: 29962441)
1. [A 36-year-old woman with primary central nervous system lymphoma diagnosed by twice brain biopsies, showing relapsing and remitting brain lesions].
Takasone K; Kobayashi C; Katoh N; Kaneko T; Shingu K; Ikeda SI
Rinsho Shinkeigaku; 2018 Jul; 58(7):440-444. PubMed ID: 29962441
[TBL] [Abstract][Full Text] [Related]
2. [Misleading cerebral arterial wall gadolinium-enhancement in malignant lymphoma].
Inoue H; Sakurai K; Kanou Y; Yamada K; Yuasa H
Rinsho Shinkeigaku; 2018 Jul; 58(7):456-459. PubMed ID: 29962444
[TBL] [Abstract][Full Text] [Related]
3. [Case of 55-year-old female with primary central nervous system lymphoma, presenting with brain and eye lesions and long-term relapsing/remitting course].
Sasaki T; Nakayama T; Kitamura M; Kakuta Y; Imafuku I
Rinsho Shinkeigaku; 2015; 55(8):567-72. PubMed ID: 26156255
[TBL] [Abstract][Full Text] [Related]
4. Spontaneously relapsing and remitting primary CNS lymphoma in an immunocompetent 45-year-old man.
Partap S; Spence AM
J Neurooncol; 2006 Dec; 80(3):305-7. PubMed ID: 16794747
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Evaluation in Primary CNS Lymphoma.
Lukas RV; Riedell P; Horowitz PM; Pytel P; Kamson DO
Neurologist; 2018 Mar; 23(2):53-54. PubMed ID: 29494436
[TBL] [Abstract][Full Text] [Related]
6. A Rare Case of Spontaneous Remission and Relapse of a Primary Central Nervous System Lymphoma.
Ramos R; Fernandes JS; Almeida M; Almeida R
Acta Med Port; 2018 Dec; 31(12):777-783. PubMed ID: 30684376
[TBL] [Abstract][Full Text] [Related]
7. Primary Central Nervous System Lymphoma with Associated Demyelination and Creutzfeldt Astrocytes.
Achi HE; Lally JE; Riascos RF; Zhu JJ; Tandon N; Esquenazi Y; Bhattacharjee MB; Ballester LY
Ann Clin Lab Sci; 2018 Jul; 48(4):534-537. PubMed ID: 30143499
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic red flags: steroid-treated malignant CNS lymphoma mimicking autoimmune inflammatory demyelination.
Barrantes-Freer A; Engel AS; Rodríguez-Villagra OA; Winkler A; Bergmann M; Mawrin C; Kuempfel T; Pellkofer H; Metz I; Bleckmann A; Hernández-Durán S; Schippling S; Rushing EJ; Frank S; Glatzel M; Matschke J; Hartmann C; Reifenberger G; Müller W; Schildhaus HU; Brück W; Stadelmann C
Brain Pathol; 2018 Mar; 28(2):225-233. PubMed ID: 28213912
[TBL] [Abstract][Full Text] [Related]
9. Different imaging patterns of PCNSL and IVL: a case report.
Jeon SH; Kang MK; Lee SJ; Shin BS; Kang HG
BMC Neurol; 2019 Dec; 19(1):311. PubMed ID: 31795989
[TBL] [Abstract][Full Text] [Related]
10. FDG-PET in immunocompetent patients with primary central nervous system lymphoma: correlation with MRI and clinical follow-up.
Palmedo H; Urbach H; Bender H; Schlegel U; Schmidt-Wolf IG; Matthies A; Linnebank M; Joe A; Bucerius J; Biersack HJ; Pels H
Eur J Nucl Med Mol Imaging; 2006 Feb; 33(2):164-8. PubMed ID: 16220304
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance features of primary central nervous system lymphoma in the immunocompetent patient: a pictorial essay.
Yap KK; Sutherland T; Liew E; Tartaglia CJ; Pang M; Trost N
J Med Imaging Radiat Oncol; 2012 Apr; 56(2):179-86. PubMed ID: 22498191
[TBL] [Abstract][Full Text] [Related]
12. Primary central nervous system lymphomas (PCNSL): MRI response criteria revised.
Schlegel U; Jürgens A; Pels H
Neurology; 2006 Apr; 66(8):1287; author reply 1287. PubMed ID: 16636266
[No Abstract] [Full Text] [Related]
13. Inflammatory demyelinating brain lesions heralding primary CNS lymphoma.
Husseini L; Saleh A; Reifenberger G; Hartung HP; Kieseier BC
Can J Neurol Sci; 2012 Jan; 39(1):6-10. PubMed ID: 22384490
[TBL] [Abstract][Full Text] [Related]
14. Demyelination as a harbinger of lymphoma: a case report and review of primary central nervous system lymphoma preceded by multifocal sentinel demyelination.
Kvarta MD; Sharma D; Castellani RJ; Morales RE; Reich SG; Kimball AS; Shin RK
BMC Neurol; 2016 May; 16():72. PubMed ID: 27206499
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
16. Utility of post-therapy brain surveillance imaging in the detection of primary central nervous system lymphoma relapse.
Fossard G; Ferlay C; Nicolas-Virelizier E; Rey P; Ducray F; Jouanneau E; Faurie P; Belhabri A; Sunyack MP; Chassagne-Clément C; Thiesse P; Sebban C; Biron P; Blay JY; Ghesquières H
Eur J Cancer; 2017 Feb; 72():12-19. PubMed ID: 28012348
[TBL] [Abstract][Full Text] [Related]
17. Primary central nervous system lymphomas (PCNSL): MRI response criteria revised.
Küker W; Nägele T; Thiel E; Weller M; Herrlinger U
Neurology; 2005 Oct; 65(7):1129-31. PubMed ID: 16217075
[TBL] [Abstract][Full Text] [Related]
18. Primary central nervous system lymphoma in a patient treated with natalizumab.
Schweikert A; Kremer M; Ringel F; Liebig T; Duyster J; Stüve O; Hemmer B; Berthele A
Ann Neurol; 2009 Sep; 66(3):403-6. PubMed ID: 19798640
[TBL] [Abstract][Full Text] [Related]
19. Neuroinflammation preceding primary central nervous system lymphoma (PCNSL) - Case reports and literature review.
Norrington M; Rathi N; Jenkinson MD; Mills SJ
J Clin Neurosci; 2021 Jul; 89():381-388. PubMed ID: 34083111
[TBL] [Abstract][Full Text] [Related]
20. A rare case of nonenhancing primary central nervous system lymphoma mimic multiple sclerosis.
Chen H; Dong H
Neurosciences (Riyadh); 2015 Oct; 20(4):380-4. PubMed ID: 26492120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
